C12N 2770/24261
Methods of inactivation or attenuation
C12N2770/24261 (Methods of inactivation or attenuation) appears on 20 US grants and 26 published applications in this corpus.
Search patents in C12N- Granted patents
- 20
- Published applications
- 26
- Assignees
- 26
- Inventors
- 69
- Latest grant
- 16 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 3 |
| 2005 | 2 | 2 |
| 2006 | 2 | 2 |
| 2007 | 1 | 0 |
| 2008 | 0 | 5 |
| 2009 | 1 | 0 |
| 2010 | 0 | 2 |
| 2011 | 1 | 1 |
| 2012 | 2 | 2 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method of purifying whole virus particles16 Dec 2025US 12,497,598 B2Hvidovre Hospital
- Development of methods for production of a whole virus vaccine candidate stock and novel adaptive mutations in hepatitis C virus16 Apr 2019US 10,258,687 B2Hvidovre Hospital
- Substituted nucleosides, nucleotides and analogs thereof12 Sep 2017US 9,758,544 B2Alios BioPharma, Inc.
- Modified Hepatitis C virus proteins14 Jul 2015US 9,079,950 B2Macfarlane Burnet Institute for Medical Research and Public Health Limited
- Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1)30 Sep 2014US 8,846,891 B2Hvidovre Hospital
- Zika and hcv attenuated viruses and use thereof2 Jul 2026US 2026/0185060 A1Bar-Ilan University
- Method of purifying whole virus particles31 Aug 2023US 2023/0272350 A1Hvidovre Hospital
- Development of methods for production of a whole virus vaccine candidate stock and novel adaptive mutations in hepatitis c virus28 Sep 2017US 2017/0274067 A1Hvidovre Hospital
- Substituted nucleosides, nucleotides and analogs thereof23 Jun 2016US 2016/0176911 A1Alios BioPharma, Inc.
- Spiro ring compounds as hepatitis c virus (hcv) inhibitors20 Aug 2015US 2015/0232509 A1Sunshine Lake Pharma Co., Ltd.
Most cited
By later US patents
- DNA transfection system for the generation of infectious influenza virus91US 6,951,754 B2St. Jude Children?S Research Hospital · 2005
- Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA50US 6,063,628 AUniversity of Washington · 2000
- DNA transfection system for the generation of infectious influenza virus45US 7,312,064 B2St. Jude Children's Research Hosptal · 2007
- DNA-transfection system for the generation of infectious influenza virus41US 7,972,843 B2St. Jude Children?S Research Hospital · 2011
- DNA transfection system for the generation of negative strand RNA virus30US 8,309,099 B2St. Jude Children?S Research Hospital · 2012